🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Dome-Only Aneurysm Coiling in Severe Aneurysmal Subarachnoid Hemorrhage

Recruitingn/aAges 18 Years - anyAllUniversity of Louisville
NCT07250958 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The DOME study is a clinical trial exploring a new treatment approach for patients who suffered a severe brain bleed due to an aneurysm.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * 18 years or older * CT confirmed aSAH with an angiographically detected aneurysm * World Federation of Neurological Sciences (WFNS) aSAH grade 3-5 aneurysm * LAR available and gives consent within 72 hours after the onset of aSAH (or last known normal Exclusion Criteria: * Patients whose aneurysm judged appropriate for balloon-assisted coiling * Patients whose aneurysm is bleeding from the "neck" * Patients who are clinically judged to suffer imminent death within 24 hours. * Pregnancy or positive urine pregnancy test
💊

What it tests

  • Not listed
📍

Where

1 site
University of Louisville Hospital
Louisville, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy